Frontiers in Molecular Biosciences · Nov 18, 2026

High-throughput Immunoglobulin G N-glycosylation profiling for identification of metabolic syndrome

By Siyi Dun, Yan Zhang, Anlu Ouyang et al.

Background Metabolic syndrome (MetS) is a growing epidemic. Studies have implied that whole plasma N-glycans are associated with MetS. This study was designed to compare the profiles of immunoglobulin (Ig) G N-glycans between individuals with MetS and non-MetS participants. Methods Individuals with MetS were enrolled from Xicheng District of Beijing. Plasma IgG N-glycans were assayed using hydrophilic interaction liquid chromatography with ultra-high-performance liquid chromatography (HILIC-UPLC), detecting 24 glycan peaks (GPs) and calculating 54 derived traits. Logistic regression was used to explore MetS-related glycans, and receiver operating characteristic (ROC) curves were employed to determine the performance of the glycan-based model in identifying individuals with MetS. Results Among 537 participants, 62 (11.55%) were diagnosed with MetS. The between-group test showed that seven initial GPs and 20 derived glycan traits were associated with MetS, while 12 GPs and 18 derived glycan traits demonstrated a strong link to MetS-related risks. Least absolute shrinkage and selection operator (LASSO) regression was applied to screen the initial glycan peaks, which identified seven significant glycan peaks. A diagnostic model combining 7 GPs with age and body mass index (BMI) manifested an optimal discriminatory ability for identifying MetS, with an area under the ROC curve (AUC) of 0.88 (95% CI: 0.84 to 0.92). Conclusion IgG N-glycome is a potential biomarker of MetS and may aid in its diagnosis and inform preventive strategies.

The paperJournal siteBiomarkers

AgingResearch.News